WIF1 Qualitative-Methylation from Peripheral Blood Could Not Be Used as Biomarker for The Risk of Nasopharyngeal Carcinoma or Smoking Behavior in Yogyakarta Panel
Abstract
BACKGROUND: Tobacco smoking plays an important role in nasopharyngeal carcinoma (NPC) risk. The Wingless-related integration site (WNT) Inhibitory Factor 1 (WIF1) as one of the tumor suppressor gene (TSG), functions to control cell proliferation through suppression of WNT signaling pathway. WIF1 methylation is one of epigenetic mechanisms which causes overactivated of WNT pathway in NPC development. WIF1 methylation from buffy coat related to smoking status and NPC risk is not known yet.
METHODS: This was a nested case-control study involving 39 newly diagnosed NPC patients and 40 healthy controls. All subjects were enrolled at Dr. Sardjito Hospital, Yogyakarta. Subjects were male, with known smoking status, duration, and quantity of cigarette consumed. Parallel DNA isolated from buffy coat was used for WIF1 DNA methylation analysis, by using methylation-specific PCR (MSP) method. Chi-square analysis was used to determine distribution of differences among groups. Two tailed p-value≤0.05 was considered as statistically significant.
RESULTS: No significant difference between WIF1 methylation of cases and controls (p=0.30), nor smoking habit among smokers (p=0.51) and non-smokers (p=0.43).
CONCLUSION: WIF1 methylation from buffy coat could not be used as an NPC marker nor as a smoking behavior marker.
KEYWORDS: buffy coat, cigarette smoking, methylation, nasopharyngeal carcinoma, WIF1
Full Text:
PDFReferences
Brennan B. Nasopharyngeal carcinoma. Orphanet J Rare Dis. 2006; 1: 23, CrossRef.
WHO [Internet]. Globocan 2012: Estimated Cancer Incidence Mortality and Prevalence Worldwide in 2012. World Health Organization. 2012 [cited 2018 Apr 5]. Available from: http://globocan.iarc.fr/.
Tsao SW, Yip YL, Tsang CM, Pang PS, Lau VMY, Zhang G, et al. Etiological factors of nasopharyngeal carcinoma. Oral Oncol. 2014; 50: 330-8, CrossRef.
Dai W, Cheung AKL, Ko JMY, Cheng Y, Zheng H, Ngan RKC, et al. Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma. Cancer Med. 2015; 4: 1079-90, CrossRef.
Tsao SW, Tsang CM, Lo KW. 2017. Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond B Biol Sci. 2017; 372: pii: 20160270, CrossRef.
Zheng Y, Li X, Jiang Y, Xu Y, Song B, Zhou Q, et al. Promoter hypermethylation of Wnt inhibitory factor-1 in patients with lung cancer. Medicine (Baltimore). 2016; 95: e5433, CrossRef.
Tulalamba W, Janvilisri T. Nasopharyngeal carcinoma signaling pathway: an update on molecular biomarkers. Int J Cell Biol. 2012; 2012: 594681, CrossRef.
Hutajulu SH, Indrasari SR, Indrawati LP, Harijadi A, Duin S, Haryana SM, et al. Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population. Mol Cancer. 2011; 10: 48, CrossRef.
Risanti ED, Kurniawan A, Wahyuningsih L, Dwianingsih EK, Rinonce HT, Fachiroh J. Association of peripheral blood RASSF1A and CDKN2A methylation status with smoking behaviour in nasopharyngeal carcinoma. Indones Biomed J. 2018; 10: 123-7, CrossRef.
Ye M, Huang T, Ni C, Yang P, Chen S. Diagnostic capacity of RASFF1A promoter methylation as a biomarker in tissue, brushing, and blood samples of nasopharyngeal carcinoma. EBioMedicine. 2017; 18: 32-40, CrossRef.
Li S, Wong EM, Bui M, Nguyen TL, Joo JHE, Stone J, et al. Causal effect of smoking on DNA methylation in peripheral blood: A twin and family study. Clin Epigenetics. 2018; 10: 1-12, CrossRef.
Xu FH, Xiong D, Xu YF, Cao SM, Xue WQ, Qin HD, et al. An epidemiological and molecular study of the relationship between smoking, risk of nasopharyngeal carcinoma, and Epstein–Barr Virus activation. J Natl Cancer Inst. 2012; 104: 1396-410, CrossRef.
Dai W, Zheng H, Cheung AKL, Lung ML. Genetic and epigenetic landscape of nasopharyngeal carcinoma. Chinese Clin Oncol. 2016; 5: 16, CrossRef.
Li L, Choi JY, Lee KM, Sung H, Park SK, Oze I, et al. DNA methylation in peripheral blood: a potential biomarker for cancer molecular epidemiology. J Epidemiol. 2012; 22: 384-94, CrossRef.
Otterdijk SD Van, Binder AM, Szarc K, Schwald J, Michels KB. DNA methylation of candidate genes in peripheral blood from patients with type 2 diabetes or the metabolic syndrome. PLoS One. 2017; 12: e0180955, CrossRef.
Nakatochi M, Ichihara S, Yamamoto K, Naruse K, Yokota S, Asano H, et al. Epigenome-wide association of myocardial infarction with DNA methylation sites at loci related to cardiovascular disease. Clin Epigenetics. 2017; 9: 54, CrossRef.
Luo X, Huang R, Sun H, Liu Y, Bi H, Li J, et al. Methylation of a panel of genes in peripheral blood leukocytes is associated with colorectal cancer. Sci Rep. 2016; 6: 29922, CrossRef.
Severi G, Southey MC, English DR, Jung C, Lonie A, McLean C, et al. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer. Breast Cancer Res Treat. 2014; 148: 665-73, CrossRef.
Zhang Z, Sun D, Hutajulu SH, Nawaz I, Van DN, Huang G, et al. Development of a non-invasive method, multiplex methylation specific PCR (MMSP), for early diagnosis of nasopharyngeal carcinoma. PLoS ONE. 2011; 7: e45908, CrossRef.
Zhao Z, Liu W, Liu J, Wang J, Luo B. The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer. J Med Virol. 2017; 89: 1844-51, CrossRef.
Lee BB, Lee EJ, Jung EH, Chun HK, Chang DK, Song SY, et al. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer. Clin Cancer Res. 2009; 15: 6185-91, CrossRef.
Lee KWK, Pausova Z. Cigarette smoking and DNA methylation. Front Genet. 2013; 4: 132, CrossRef.
Yoshino M, Suzuki M, Lei T, Yasumitsu M, Hidehisa H, Tatsuro O, et al. Promoter hypermethylation of the p16 and Wif-1 genes as an independent prognostic marker in stage IA non-small cell lung cancers. Int J Oncol. 2009; 35: 4-11, CrossRef.
Huang Y, Chang X, Lee J, Cho YG, Zhong X, Park IS, et al. Cigarette smoke induces promoter methylation of single-stranded DNAbinding protein 2 in human esophageal squamous cell carcinoma. Int J Cancer. 2011; 128: 2261-73, CrossRef.
Claus R, Wilop S, Hielscher T, Sonnet M, Dahl E, Galm O, et al. A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCR. Epigenetics. 2012; 7: 772-80, CrossRef.
Lim U, Song M-A. Dietary and lifestyle factors of DNA methylation. In: Dumitrescu RG, Verma M, editors. Cancer Epigenetics: Methods and Protocols. Totowa, NJ: Humana Press; 2012. p.359-76, CrossRef.
Pacchierotti F, Spanò M. Environmental impact on DNA methylation in the germline: state of the art and gaps of knowledge. Biomed Res Int. 2015; 2015:123484, CrossRef.
DOI: https://doi.org/10.18585/inabj.v11i3.810
Copyright (c) 2019 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute